ADC Contract Manufacturing Market, 2020-2030
New York, Dec. 11, 2020 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report ADC Contract Manufacturing Market, 2020-2030 - https://www.reportlinker.com/p03290025/?utm source=GNW Over time, clinical researchers have been able to further their understanding of the intricacies of ADC design and have also improved the development process of these complex pharmacological interventions. Some of the recently approved ADC therapeutics include BLENREP® (2020), TRODELVYTM (2020), PadcevTM (2019) and POLIVY® (2019). In addition, there are close to 250 unique ADC product candidates under development. Several big pharma players, including AstraZeneca, GlaxoSmithKline, Pfizer, Roche and Takeda, have also acquired stake in this market. Moreover, the fact that companies involved in the development of ADCs, have received over USD 5 billion in capital investments (since 2011), attests to the therapeutic potential and growing p